Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-18-051725

Co-Chief Executive Officer gave up 3,783 shares (to pay taxes)

  • Co-Chief Executive Officer acquired 10,938 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

WEST MICHAEL D · Co-Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-09-17 Exercise or conversion : show line 1 in the form +10,938 897,696 D
2018-09-17 Shares withheld for taxes : show line 2 in the form −3,783 $2.31 $8,739 893,913 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-09-17 Exercise or conversion : show line 3 in the form Restricted Stock Units −10,938 0 D
Loading xslF345X03/doc4.xml…